Mathias Locher
Corporate Officer/Principal presso Covagen AG
Profilo
Mathias Locher is currently the Chief Development Officer at Covagen AG.
Previously, he held the position of Vice President-PreClinical Development at Micromet AG.
From 2007 to 2011, he worked at Merck Serono SA as the Global Head-Drug Metabolism & Pharmacokinetics.
He also served as the Chief Development Officer at Heidelberg Pharma AG from 2021 to 2023.
Dr. Locher obtained a doctorate degree from Eberhard Karls Universität Tübingen.
Posizioni attive di Mathias Locher
Società | Posizione | Inizio |
---|---|---|
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Corporate Officer/Principal | - |
Precedenti posizioni note di Mathias Locher
Società | Posizione | Fine |
---|---|---|
HEIDELBERG PHARMA AG | Corporate Officer/Principal | 01/04/2023 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | 01/01/2011 |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Corporate Officer/Principal | - |
Formazione di Mathias Locher
Eberhard Karls Universität Tübingen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
HEIDELBERG PHARMA AG | Health Technology |
Aziende private | 3 |
---|---|
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Health Technology |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
- Borsa valori
- Insiders
- Mathias Locher